• English
  • عربي / Arabic
  • മലയാളം / Malayalam
Home > Doctors > Dr Rahul T Sankar

Dr Rahul T Sankar

Dr Rahul T Sankar

Consultant

Medical Oncology

  • BMH Kannur

Dr Rahul T Sankar

Dr. Rahul T. Sankar is a highly qualified and dedicated Medical Oncologist with comprehensive training in the diagnosis and management of cancer. With strong academic credentials and advanced clinical expertise, he provides evidence-based, patient-centric cancer care across a wide spectrum of malignancies.He has completed his MD in Radiation Oncology and holds multiple advanced super-specialty qualifications in Medical Oncology, including DM, DrNB, and ECMO. In addition, he has obtained MRCP (UK) in Medical Oncology, reflecting international standards of training and clinical excellence.

  • DrNB, Medical Oncology - National Board of Examination, India - 2022
  • DM, Medical Oncology - Madras Medical College, MGR University Chennai - 2021
  • MD, Radiation Oncology - Kerala University Of Health Sciences, Thrissur - 2017
  • MBBS - Government Medical College Thrissur - 2011
  • Consultant - Medical Oncology - Baby Memorial Hospital, Kannur - 2026 - Present
  • Senior Specialist -  Aster MIMS, Calicut.- 2022 - 2023
  • Assistant Professor - Govt. Kilpauk Medical College, Chennai - 2021 - 2022 
  • Gynecologic Cancer
  • Lymphoma
  • Immunotherapy
  • Targeted Therapy
  • MRCP(UK) Medical Oncology - 2023
  • ECMO, Medical Oncology - 2022
  • Published the research paper "EFFECT OF DEFINITIVE CONCURRENT CHEMO RADIOTHERAPY IN PATIENTS WITH INOPERABLE ESOPHAGEAL SQUAMOUS CELLCARCINOMA - A PROSPECTIVE STUDY" in International Journal of Contemporary Medical Research (IJCMR-2018)
  • Published the research paper "CLINICAL PROFILES AND SURVIVAL ANALYSIS OF PATIENTS WITH CARCINOMA CERVIX AT A TERTIARY CARE CENTRE: A RETROSPECTIVE STUDY" in International Journal of Scientific Study (IJSS-2019)
  • Published the research paper "PROSPECTIVE ANALYSIS OF QUALITY OF LIFE IN PATIENTS WITH INOPERABLE ESOPHAGEAL CARCINOMA WITH DEFINITIVE CONCURRENT CHEMORADIOTHERAPY - SINGLE CENTRE STUDY" in International Journal of Scientific Study (IJSS-2019)
  • Evaluation of responses to total neoadjuvant treatment in primarily inoperable rectal cancers a prospective study (on going)
  • Prevalence of breast cancer risk factorsand screening practicesamongst female tertiary healthcare workers in Chennai - A cross sectional study (on going)

Health Blogs

View More

Real Voices That Matter

Related Doctors

View More